Skip to main content
Back
SKHCF logo

Sonic Healthcare Limited

Data quality: 100%
SKHCF
OTC Healthcare Medical - Diagnostics & Research
$15.00
▼ $1.00 (-6.25%)
Mkt Cap: 7.41B
Also listed as SKHHY OTC
Day Range
$15.00 $15.00
52-Week Range
$12.70 $19.34
Volume
180
50D / 200D Avg
$14.99 / $15.85
Prev Close
$15.00

Price History

Financial Trends

Peer Comparison

vs Healthcare sector median (626 peers)

Metric Stock Sector Median
P/E 14.4 0.4
P/B 0.9 2.9
ROE % 6.3 3.7
Net Margin % 5.3 3.8
Rev Growth 5Y % 2.5 10.0
D/E 0.6 0.2

Key Takeaways

Revenue grew 2.45% annually over 5 years — modest growth
Generating 960.55M in free cash flow
P/E of 14.43 — trading at a low valuation
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 5.51%
Cash machine — converts 187.02% of earnings into free cash flow
Capital efficient — spends only 3.49% of revenue on capex

Growth

Revenue Growth (5Y)
2.45%
Revenue (1Y)7.96%
Earnings (1Y)0.49%
FCF Growth (3Y)-0.69%

Quality

Return on Equity
6.32%
ROIC16.23%
Net Margin5.32%
Op. Margin30.28%

Safety

Debt / Equity
0.62
Current Ratio1.17
Interest Coverage16.18

Valuation

P/E Ratio
14.43
P/B Ratio0.89
EV/EBITDA4.08
Dividend Yield0.04%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 7.96% Revenue Growth (3Y) 8.82%
Earnings Growth (1Y) 0.49% Earnings Growth (3Y) -13.41%
Revenue Growth (5Y) 2.45% Earnings Growth (5Y) -20.95%
Profitability
Revenue (TTM) 9.65B Net Income (TTM) 513.60M
ROE 6.32% ROA 3.20%
Gross Margin 33.05% Operating Margin 30.28%
Net Margin 5.32% Free Cash Flow (TTM) 960.55M
ROIC 16.23% FCF Growth (3Y) -0.69%
Safety
Debt / Equity 0.62 Current Ratio 1.17
Interest Coverage 16.18 Dividend Yield 0.04%
Valuation
P/E Ratio 14.43 P/B Ratio 0.89
P/S Ratio 0.77 PEG Ratio 0.00
EV/EBITDA 4.08 Dividend Yield 0.04%
Market Cap 7.41B Enterprise Value 11.91B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 9.65B 8.93B 8.14B 9.34B 8.75B
Net Income 513.60M 511.09M 684.98M 1.46B 1.32B
EPS (Diluted) 1.07 1.07 1.45 3.02 2.73
Gross Profit 3.19B 7.48B 6.87B 7.74B 3.43B
Operating Income 2.92B 2.69B 2.63B 3.52B 3.18B

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 16.05B 14.83B 13.56B 12.55B 11.76B
Total Liabilities 7.58B 6.75B 5.64B 5.12B 5.26B
Shareholders' Equity 8.32B 7.92B 7.74B 7.27B 6.38B
Total Debt 5.17B 4.52B 3.10B 3.01B 3.23B
Cash & Equivalents 673.77M 645.00M 797.99M 780.00M 899.83M
Current Assets 2.61B 2.35B 2.13B 2.31B 2.28B
Current Liabilities 2.22B 2.32B 1.88B 2.08B 2.22B

Strategy Scores

This stock passed the criteria for 2 strategies

Score = fit strength (0–100)
Rank = position among all matches
Custom Cash Flow Compounder
#195 of 1024
62
Growth Price/Sales Ratio Focus (Ken Fisher)
#467 of 616
19

Recent Activity

Entered Cash Flow Compounder
Mar 24, 2026
Entered Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026